At Abyntek Biopharma, they understand that the selection and validation of antibodies is crucial to the success of any research project.
That is why, under their ABYLABEL brand, they have developed AbyPanels, a tool designed to optimize this process and ensure reliable and reproducible results.
These are kits that include a selection of specific antibodies (monoclonal, polyclonal, or recombinant) in small quantities (20 μl) targeting the same target. This variety allows researchers to evaluate and determine which antibody is most suitable for their specific needs, thus ensuring maximum efficacy in their experiments.
At Abyntek Biopharma, they are committed to providing solutions that enhance the quality and efficiency of scientific research. With AbyPanels, they are taking another step toward excellence in antibody validation.
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Proceeds to support clinical development of lead first-in-class progra...
